PD Dr. Matthias Rübner

Department of Obstetrics and Gynaecology Medizinische Fakultät

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2023) Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, et al. Journal article Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis (2023) Schulmeyer C, Fasching P, Häberle L, Meyer J, Schneider M, Wachter D, Rübner M, et al. Journal article RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer (2023) Behrens A, Wurmthaler L, Heindl F, Gaß P, Häberle L, Volz B, Hack C, et al. Journal article Improved HER2 Tumor Segmentation with Subtype Balancing Using Deep Generative Networks (2023) Öttl M, Steenpaß J, Rübner M, Geppert CI, Qiu J, Wilm F, Hartmann A, et al. Conference contribution Expression of disialoganglioside GD2 in breast cancer subtypes (2022) Gaß P, Kailayangiri S, Hübner H, Rübner M, Hartmann A, Häberle L, Völkl S, et al. Conference contribution Methodological Establishment of an in-vitro ADCC Assay by using patient-specific Immune Cells (2022) Lehle S, Völkl S, Rübner M, Emons J, Seitz K, Beckmann M, Fasching P, Hübner H Conference contribution, Conference Contribution Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer (2022) Fasching P, Liu D, Scully S, Ingle JN, Lyra PC, Rack B, Hein A, et al. Journal article Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer (2022) Ramachandran D, Dennis J, Fachal L, Schurmann P, Bousset K, Huelse F, Mao Q, et al. Journal article Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia) (2022) Hein A, Kehl S, Häberle L, Tiemann C, Peuker R, Mereutanu D, Stumpfe F, et al. Journal article Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. (2022) Meagher NS, Gorringe KL, Wakefield MJ, Bolithon A, Pang CNI, Chiu DS, Anglesio MS, et al. Journal article